Cleared Traditional

Careverse CoronaryDoc (Careverse CoronaryDoc) (K251656) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K251656 · Careverse Technology Pte. , Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2025
Decision
97d
Days
Class 2
Risk

K251656 is an FDA 510(k) clearance for the Careverse CoronaryDoc (Careverse CoronaryDoc). Classified as Automated Radiological Image Processing Software within the QIH classification (a category dominated by AI-based automated radiology processing systems), Class II - Special Controls.

Submitted by Careverse Technology Pte. , Ltd. (Singapore, SG). The FDA issued a Cleared decision on September 4, 2025 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Careverse Technology Pte. , Ltd. devices

Submission Details

510(k) Number K251656 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2025
Decision Date September 04, 2025
Days to Decision 97 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 107d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QIH Automated Radiological Image Processing Software
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
Definition To Provide Automated Radiological Image Processing And Analysis Tools. Software Implementing Artificial Intelligence Including Nonadaptive Machine Learning Algorithms Trained With Clinical And/or Artificial Data. In These Devices, The Algorithm Training Data Typically Impacts Device Performance. Adaptive Ai Algorithms Are Not Within Scope Of This Product Code.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - QIH Automated Radiological Image Processing Software

All 297
Devices cleared under the same product code (QIH) and FDA review panel - the closest regulatory comparables to K251656.
InferOperate Suite
K250237 · Beijing Infervision Healthcare Medical Technology Co., Ltd. · Sep 2025
AngioWaveNet
K244002 · Angiowave Imaging, Inc. · Sep 2025
Segmentron Viewer
K251072 · DGNCT, LLC · Sep 2025
Tempus Pixel
K252539 · Arterys, Inc. · Sep 2025
PRAEVAorta®2
K243859 · Nurea · Aug 2025
VistaSoft 4.0 and VisionX 4.0
K250947 · Durr Dental SE · Aug 2025